Sarepta Therapeutics (United States) - Academic Profile

Publications

Mode of Inhibition of Respiratory Syncytial Virus by a Plant Flavonoid, SP-303

Dale L. Barnard , John H. Huffman , Laurence R. Meyerson +1 more

A natural-product polyphenolic polymer of molecular weight 2,100 daltons designated SP-303, was found to have antiviral activity against respiratory syncytial virus (RSV) in the...

1993 Chemotherapy 39 citations

U.S. health plan coverage of Neuromuscular Disease Therapies: An assessment of policy availability and restrictions

Julia A Rucker , Alex R Cockerham

Background: Health plan policies managing neuromuscular disease (NMD) therapies may impose burdensome requirements on patients and providers. While prior research has explored p...

2025 Journal of Neuromuscular Diseases 0 citations

Affiliated Researchers

Institution Info

Type: company
Country: US
Publications: 2
Citations: 39

External Links

Identifiers

ROR: https://ror.org/054f2wp19

Publications

Mode of Inhibition of Respiratory Syncytial Virus by a Plant Flavonoid, SP-303

U.S. health plan coverage of Neuromuscular Disease Therapies: An assessment of policy availability and restrictions

Affiliated Researchers

Dale L. Barnard

John H. Huffman

R. W. Sidwell

Alex R Cockerham

Institution Info

External Links

Identifiers

Research Output Over Time